Evidence map›Paper›PMID 36900325›Full record

ArticleCancers2023

Label Distribution Learning for Automatic Cancer Grading of Histopathological Images of Prostate Cancer.

Mizuho Nishio, Hidetoshi Matsuo, Yasuhisa Kurata, Osamu Sugiyama, Koji Fujimoto

Full text read
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mizuho NishioDepartment of Radiology, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan.
Hidetoshi MatsuoDepartment of Radiology, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan.
Yasuhisa KurataDepartment of Diagnostic Imaging and Nuclear Medicine, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.
Osamu SugiyamaDepartment of Informatics, Kindai University, 3-4-1 Kowakae, Higashiosaka City 577-8502, Japan.
Koji FujimotoDepartment of Real World Data Research and Development, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.

Funding

JSPS 22K07665JSPS JP19K17232
6 · The paper itself

Abstract

We aimed to develop and evaluate an automatic prediction system for grading histopathological images of prostate cancer. A total of 10,616 whole slide images (WSIs) of prostate tissue were used in this study. The WSIs from one institution (5160 WSIs) were used as the development set, while those from the other institution (5456 WSIs) were used as the unseen test set. Label distribution learning (LDL) was used to address a difference in label characteristics between the development and test sets. A combination of EfficientNet (a deep learning model) and LDL was utilized to develop an automatic prediction system. Quadratic weighted kappa (QWK) and accuracy in the test set were used as the evaluation metrics. The QWK and accuracy were compared between systems with and without LDL to evaluate the usefulness of LDL in system development. The QWK and accuracy were 0.364 and 0.407 in the systems with LDL and 0.240 and 0.247 in those without LDL, respectively. Thus, LDL improved the diagnostic performance of the automatic prediction system for the grading of histopathological images for cancer. By handling the difference in label characteristics using LDL, the diagnostic performance of the automatic prediction system could be improved for prostate cancer grading.

Indexed as

deep learningdigital pathologyGleason scoreISUP scorelabel distribution learningprostate cancer

Identifiers

PMID36900325
PMCPMC10000939

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read5
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.